SPL 2.13% 9.6¢ starpharma holdings limited

Announcements surrounding a pre-clinical product is somewhat...

  1. 357 Posts.
    lightbulb Created with Sketch. 31

    Announcements surrounding a pre-clinical product is somewhat irrelevant for many years to come.


    Re-focus on what matters in my opinion, holding your breath for the North America partnership for Vivagel BV and the FDA decision.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.